ALMS (Alumis) Short Ratio


ALMS Alumis Inc ALMS
12 GF Score
Price $28.12
! 5 Warning Signs
View Full Analysis

What is Alumis Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ALMS
12GF Score
Alumis Inc ALMS
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alumis Business Description

Address 280 East Grand Avenue, South San Francisco, CA, USA, 94080
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
12GF Score

Get the complete analysis for ALMS

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.12
Price